Article
A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants.
Vaccine - 2 Jan 2013
Bustamante Leyla Y, Bartholdson S Josefin, Crosnier Cecile, Campos Marta G, Wanaguru Madushi, Nguon Chea, Kwiatkowski Dominic P, Wright Gavin J, Rayner Julian C
Abstract excerpt
The lack of an effective licensed vaccine remains one of the most significant gaps in the portfolio of tools being developed to eliminate Plasmodium falciparum malaria. Vaccines targeting erythrocyte invasion - an essential step for both parasite development and malaria pathogenesis - have faced the particular challenge of genetic diversity. Immunity-driven balancing selection pressure on parasite invasion...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
